• Info
  • Insider Ownership

Insider Trading & Ownership of DRAGSA 96 LLC

Location
Greenwich, CT
Summary
The estimated value of insider holdings of DRAGSA 96 LLC is at least $37,554,630 dollars as of 21 Jan 2022. DRAGSA 96 LLC is the 10%+ Owner of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $37.55M.
Signature
/s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen (2)
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow DRAGSA 96 LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • DRAGSA 96 LLC has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $37,554,630.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Amylyx Pharmaceuticals, Inc. ($37,554,630).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of DRAGSA 96 LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMLX Amylyx Pharmaceuticals, Inc. 10%+ Owner $37,554,630 11 Jan 2022

Insider Transactions Reported by DRAGSA 96 LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.